2Keratins and keratin-associated proteins (KAPs) constitute the major structural protein components of the hair. Regulation of their expression is critical for proper hair follicle (HF) structure and function [1]. Therefore, it is important to fully elucidate the controls that regulate keratin expression. Although it is accepted that the expression of selected keratin genes underlies endocrine controls [1,2], our understanding of the complex regulation of keratin expression remains rather fragmentary. To better elucidate this regulation, human skin and HF organ culture offer an instructive, physiologically relevant research tool [1,3].In particular, very little is known on the neuroendocrine controls of keratin transcription. The importance of the latter is highlighted by the recent discovery that the "pituitary" neuropeptide hormone, prolactin, which is also expressed by human HFs, potently regulates the expression of selected human keratins on the gene and protein level [3]. Moreover, microarray analyses had provided first clues that thyroid stimulating hormone (TSH) and its proximal regulator in the hypothalamic-pituitary-thyroid axis, thyrotropin-releasing hormone (TRH), might operate as previously unsuspected modulators of human hair keratin and KAP gene transcription in situ [4][5][6]. Also, we had recently found that TSH upregulates keratin K5 gene expression and protein synthesis as well as K14 transcription in human epidermis [4]. Therefore, we have asked whether TSH operates as a novel neuroendocrine regulator of human keratins in situ, using microdissected, organ-cultured human scalp HFs as a physiologically and clinically relevant assay systems [3][4][5]. This was complemented by studying the effect of TSH on keratin expression in cultured human outer root sheath (ORS) keratinocytes (KCs).Anagen VI HFs were isolated from normal frontotemporal scalp skin obtained after written informed consent from three healthy females undergoing routine face-lift surgery, as 3 previously described [4,5], adhering to Helsinki guidelines and under a licence from the ethics committee of the University of Lübeck. HF mRNA extracts from one female patient were subjected to quantitative real time PCR (qPCR) for selected hair keratin genes after 24 hrs treatment with TSH (100 mU ml -1 ) or vehicle. For immunohistochemical analysis, isolatedHFs from additional two female patients were organ cultured for 6 days as described previously [3,4], and expression of keratins K6, K14, K17, K31, K32, K85 and MSX-2 was studied with our previously published basic immunohistology protocols [3,4] ( These qPCR analyses demonstrated that TSH downregulated transcription of KRT31 and KRT32 genes (Fig. 1A). In these qPCR analyses, KRT35 transcription was largely unaffected by TSH. Instead, transcription of its type II counterpart keratin gene, KRT85 [2], was downregulated (Fig. 1A).
4Immunohistochemical studies on TSH treated HFs confirmed the downregulation of the hair keratins also at the protein level ( Fig. 2A-C): K31 immunoreactivity, loc...